EXMceuticals now '100% focused on being a refining bioscience business in Portugal'

Inc's () Jonathan Summers speaks to Proactive London's Katie Pilbeam about their cannabis research and development.

Summers explains that the company has recently transitioned from being active in Africa to focusing their attentions solely onto Portugal.

The company recently announced securing a COVID-19 R&D-focused grant from the European Union and the Portuguese Government to accelerate their operations on creating a disposable filter for a mask.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EXMceuticals named herein, including the promotion by the Company of EXMceuticals in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE
Innocan Pharma says clinical trials demonstrate th...
EXMceuticals receives coronavirus research grant f...

By accepting you will be accessing a service provided by a third-party external to https://www.mjinvest.com/